Skip to main content

Table 1 Accuracy and precision for the quantification of ( ±)-primaquine and ( ±)-carboxyprimaquine in human EDTA plasma

From: Simultaneous and enantiospecific quantification of primaquine and carboxyprimaquine in human plasma using liquid chromatography-tandem mass spectrometry

Analyte

Sample

Nominal concentration (ng/mL)

Measured concentration (ng/mL)

Accuracy (%)

Between-assay precision (RSD)

Within-assay precision (RSD)

( +)-PRQ

LLOQ

0.571

0.591

103

7.72

9.93

QC1

1.46

1.48

101

6.38

6.32

QC2

16.8

16.8

100

6.27

3.60

QC3

195

193

98.9

3.08

3.54

ULOQ

260

256

98.5

6.77

4.00

Over curve

519

515

99.2

4.20

2.81

(−)-PRQ

LLOQ

0.571

0.556

97.4

13.3

9.08

QC1

1.46

1.43

97.9

7.12

4.54

QC2

16.8

17.1

101

6.67

1.13

QC3

195

192

98.5

1.45

1.03

ULOQ

260

252

96.9

2.80

1.05

Over curve

519

530

102

1.62

1.64

( +)-CPRQ

LLOQ

2.44

2.39

97.9

8.12

4.93

QC1

7.32

7.28

99.5

8.84

9.13

QC2

117

116

99.1

3.34

2.50

QC3

1875

1806

96.3

7.61

2.19

ULOQ

2500

2471

98.8

9.31

2.39

Over curve

5000

4886

99.7

7.45

3.87

(−)-CPRQ

LLOQ

2.44

2.31

94.7

5.90

8.23

QC1

7.32

7.22

98.6

11.2

7.45

QC2

117

114

97.4

5.18

1.68

QC3

1875

1813

96.7

4.70

4.03

ULOQ

2500

2404

96.2

2.80

1.05

Over curve

5000

4938

98.8

1.62

1.64

  1. CPRQ, carboxyprimaquine; LLOQ, lower limit of quantification; PRQ, primaquine; QC, quality control; RSD, relative standard deviation; ULOQ, upper limit of quantification